Qualigen Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Qualigen Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2016 to Q3 2024.
  • Qualigen Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 28 %, a 67.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 28 -57.2 -67.1% Sep 30, 2024
Q2 2024 31.7 -79.5 -71.5% Jun 30, 2024
Q1 2024 45.4 -110 -70.8% Mar 31, 2024
Q4 2023 63.4 -163 -72% Dec 31, 2023
Q3 2023 85.2 -243 -74% Sep 30, 2023
Q2 2023 111 -235 -67.9% Jun 30, 2023
Q1 2023 155 -188 -54.8% Mar 31, 2023
Q4 2022 227 -75.2 -24.9% Dec 31, 2022
Q3 2022 328 +56.9 +21% Sep 30, 2022
Q2 2022 346 +167 +93.3% Jun 30, 2022
Q1 2022 343 +223 +187% Mar 31, 2022
Q4 2021 302 +214 +242% Dec 31, 2021
Q3 2021 271 +218 +414% Sep 30, 2021
Q2 2021 179 +140 +355% Jun 30, 2021
Q1 2021 119 +29.8 +33.2% Mar 31, 2021
Q4 2020 88.3 -73.7 -45.5% Dec 31, 2020
Q3 2020 52.7 -149 -73.9% Sep 30, 2020
Q2 2020 39.3 -232 -85.5% Jun 30, 2020
Q1 2020 89.6 -282 -75.9% Mar 31, 2020
Q4 2019 162 -411 -71.7% Dec 31, 2019
Q3 2019 202 -697 -77.6% Sep 30, 2019
Q2 2019 272 -474 -63.6% Jun 30, 2019
Q1 2019 372 -185 -33.2% Mar 31, 2019
Q4 2018 573 +231 +67.4% Dec 31, 2018
Q3 2018 899 +706 +366% Sep 30, 2018
Q2 2018 746 +527 +240% Jun 30, 2018
Q1 2018 557 +295 +113% Mar 31, 2018
Q4 2017 342 +0.83 +0.24% Dec 31, 2017
Q3 2017 193 -294 -60.4% Sep 30, 2017
Q2 2017 219 -542 -71.2% Jun 30, 2017
Q1 2017 262 -664 -71.7% Mar 31, 2017
Q4 2016 341 Dec 31, 2016
Q3 2016 487 Sep 30, 2016
Q2 2016 761 Jun 30, 2016
Q1 2016 925 Mar 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.